High pathological grade might discourage early invasive breast cancer patients who have a pathologic complete response to neoadjuvant systemic therapy from eliminating breast surgery.

Authors :: Li C
Wang Y
Liu M
Qu J
Zhang S
Source :: International journal of surgery (London, England) [Int J Surg] 2024 Feb 01; Vol. 110 (2), pp. 1268-1270. Date of Electronic Publication: 2024 Feb 01.
Publication Year :: 2024

Subjects :: Humans
Female
Neoadjuvant Therapy
Pathologic Complete Response
Mastectomy
Antineoplastic Combined Chemotherapy Protocols
Receptor, ErbB-2 therapeutic use
Breast Neoplasms drug therapy
Breast Neoplasms surgery
Breast Neoplasms pathology

Full Text Access

Tools